Alidya

Alidya (by Marllor Biomedical) is a pioneering Italian medical aesthetics brand recognized globally for formulating the first CE-marked, Class III injectable device specifically licensed for the prevention and treatment of cellulite (gynoid lipodystrophy). Developed by renowned researcher Prof. Pasquale Motolese, Alidya represents a clinical breakthrough in body mesotherapy.

Unlike traditional fat-reducing treatments, Alidya’s proprietary polyamino acid and iron-chelating complex targets the root vascular and extracellular pathology of cellulite. By binding toxic iron deposits, alkalizing tissue microcirculation, and improving lymphatic drainage, Alidya delivers predictable, long-term skin smoothing, tissue firming, and structural restoration for aesthetic clinics worldwide.